The possibilities of restoring sexual function in women after treatment of breast cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper describes current medical rehabilitation techniques that can restore sexual function in women who have undergone a treatment cycle for breast cancer.

Full Text

Restricted Access

About the authors

L. Idrisova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Candidate of Medical Sciences

A. Solopova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: antoninasolopova@yandex.ru
Professor

A. Makatsaria

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Professor

V. Moskvicheva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

A. Surenkov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

References

  1. Feeney L., Tormey S., Harmon D. Breast cancer and chronic pain: a mixed methods review // Ir. J. Med. Sci. - 2018. doi: 10.1007/s11845-018-1760-y.
  2. Brummett C. Chronic pain following breast surgery // Tech. Reg. Anesth. Pain Manag. - 2011; 15 (3): 124-32.
  3. Duijts S., Stolk-Vos A., Oldenburg H. et al. Characteristics of breast cancer patients who experience menopausal transition due to treatment // Climacteric. -2011; 14 (3): 362-8.
  4. Salonen P., Tarkka M., Kellokumpu-Lehtinen P. et al. Effect of social support on changes in quality of life in early breast cancer patients: a longitudinal study // Scand. J. Caring Sci. - 2013; 27 (2): 396-405.
  5. Nathorst-Boos J., Floter A., Jarkander-Rolff M. et al. Treatment with percutanous testosterone gel in postmenopausal women with decreased libidoeffects on sexuality and psychological general well-being // Maturitas. - 2006; 53 (1): 11-8.
  6. Nunez G., Pinczowski H., Zanellato R. et al. Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial // J. Pain Symptom Manag. - 2013; 45 (6): 969-79.
  7. Buijs C., Mom C., Willemse P. et al. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study // Breast Cancer Res. Treat. - 2009; 115 (3): 573-80.
  8. Анисимов В.Н. Световой режим, риск возникновения рака. Противоопухолевое действие мелатонина // Рус. мед. журн. - 2007; 25: 1915-8.
  9. Кветная Т., Бочарова К. Мелатонин и патология пожилого возраста // Врач. - 2014; 6: 53-6.
  10. Анисимов В.Н. Мелатонин: роль в организме, применение в клинике / СПб: Система, 2007; 40 с.
  11. Тананакина Е.Н. Повышение эффективности лечения маточных кровотечений у женщин репродуктивного возраста в сочетании с экстрагенитальной патологией. Дис.. канд. мед. наук. Луганск, 2017.
  12. Любота Р.В. Применение метформина в лечении рака молочной железы у больных с метаболическим синдромом // Опухоли женской репродуктивной системы. - 2015; 11 (4): 18-24.
  13. Loprinzi C., Abu-Ghazaleh S., Sloan J. et al. Phase III randomized doubleblind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer // J. Clin. Oncol. - 1997; 15 (3): 969-73.
  14. Pfeiler G., Glatz C., Konigsberg R. et al. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients // Climacteric. - 2011; 14 (3): 339-44.
  15. Donders G., Neven P., Moegele M. et al. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets Gynoflor® for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study // Breast Cancer Res. Treat. - 2014; 145 (2): 371-9.
  16. Wills S., Ravipati A., Venuturumilli P. et al. Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator // J. Oncol. Pract. - 2012; 8 (3): 144-8.
  17. Lee Y., Chung H., Kim J. et al. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial // Obstet. Gynecol. - 2011; 117 (4): 922-7.
  18. Dahir M., Travers-Gustafson D. Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy // Sexual Med. - 2014; 2 (1): 8-15.
  19. Witherby S., Johnson J., Demers L. et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study // The Oncologist. - 2011; 16 (4): 424-31.
  20. Oliveira M., Gurgel M., Amorim B. et al. Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial // PLoS One. - 2018; 13 (1): e0189176.
  21. Speck R., Gross C., Hormes J. et al. Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema // Breast Cancer Res. Treat. - 2010; 121 (2): 421-30.
  22. Талаева Ш.Ж., Чичуа Н.А., Манашева А.С. и др. Опыт применения реконструктивно-пластических операций при раке молочной железы // Онкология и радиология Казахстана. - 2016; 41 (3): 186-92.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies